[A09-05] Cholinesterase inhibitors in Alzheimer's disease - supplementary commission: rivastigmine patches and galantamine

Last updated 02.04.2012

Project no.:
A09-05

Commission:
Commission awarded on 18.12.2009 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Head and nerves

02.04.2012

But for both the drugs used to treat Alzheimer’s disease, there is also proof of harm

Press release

Accompanying information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealth.org.

Project no.	Title	Status
A05-19A	Cholinesterase inhibitors in Alzheimer's disease	Commission completed

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.